Researchers from Rush University Medical Center are partnering with colleagues from across the U.

And Australia in the biggest worldwide trial ever sponsored by the National Institute on Maturing. The Aspirin in Reducing Events in the Elderly study aims to assess whether aspirin can not only prolong lifestyle, but a complete life free from physical disability and/or dementia for healthy the elderly. According to Dr. Raj Shah, assistant professor of family medication at the Hurry Alzheimer’s Disease Center and an ASPREE investigator, Aspirin is among the most commonly used medications in the world. If the benefits of taking aspirin to maintain a life free of disability in an old person outweigh the chance of bleeding is definitely a critically essential health question to solution. In the U.S., Australia and elsewhere, people are living longer therefore identifying treatments to prolong existence free of physical disability and memory problems is increasingly important, explains ASPREE investigator Dr.Symmetry can be a breakthrough technology that enables highly accurate, yet non-invasive lung tumor remedies without requiring additional intra-fraction radiation imaging completely. Intuity ensures that not only may be the tumor’s position accounted for, but the position of nearby healthy critical structures also. Both innovations donate to a far more safe and patient-friendly treatment.

Adolor’s ENTEREG first-one fourth net revenue increases to $5.3 million Adolor Company today reported a net lack of $9.6 million, or $ per basic and diluted share, for the three months ended March 31, 2010, in comparison to a net loss of $13.2 million, or $ per basic and diluted share, for the 90 days ended March 31, 2009.3 million compared to $1.4 million for the three months ended March 31, 2009, primarily as a total consequence of growth in the amount of ordering hospitals and increased usage at ordering hospitals.